Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Mastering Healthcare Audience Segments for Enhanced Marketing Outcomes

December 14, 2024

Employing healthcare audience segments plays a pivotal role in revolutionizing marketing strategies and, in turn, elevating the standard of patient care.

The Ultimate Guide to TikTok Healthcare Advertising

November 21, 2024

TikTok has over one billion users worldwide, with more than 150 million active users in the U.S. The platform is ripe for creating content that will resonate with target audiences searching for healthcare information.

What Happens When Patient Influencers Share Their Story?

October 23, 2024

Our network of 100,000+ patients and caregivers are health advocates, influencers, and content creators who tell powerful stories every day.

Medical Device Marketing: An HCP Marketer’s Guide

October 14, 2024

In this guide, we’ll explore everything you need to know about medical device marketing and advertising, including building a digital strategy, engaging HCPs on a 1:1 basis, important ad regulations, and launching a successful campaign.

5 Things Patient Advocates Want Pharma to Know

November 9, 2020

Presented with Health Union’s trusted survey data from tens of thousands of people, chronic health patient advocates share what they want pharma to know.

Type 2 Diabetes Patient-Reported Survey Data

October 28, 2020

People living with type 2 diabetes share the stigma and judgment they feel associated with their diagnosis in new survey data from Health Union.

Hep C Patient-Reported Survey Data 2020

October 23, 2020

Just 38% of people living with HepC indicated they understood what “hepatitis C viral load” means, according to new Health Union survey data.

IBS Patient-Reported Survey Data 2020

October 19, 2020

Merely 9% of people living with IBS were currently taking a prescription IBS medication, according to new Health Union patient-reported survey data.

Healthcare Industry Thought Leadership

Contact